By: Quiver LegislationRadar
Posted: 56 minutes ago / March 4, 2026 3:37 p.m. UTC
We have received text from H.R. 7601: No Immunity for Glyphosate Act. This bill was received on 2026-02-20, and currently has 6 cosponsors.
Here is a short summary of the bill:
This bill, titled the “No Immunity for Glyphosate Act,” aims to make specific changes regarding the use of federal funds and the legal liabilities of glyphosate manufacturers. Below is a summary of its key components:
Prohibition of Federal Funds
Section 2 of the bill states that no federal funds can be used to implement, administer, or enforce an Executive order called “Promoting the National Defense by Ensuring an Adequate Supply of Elemental Phosphorus and Glyphosate-Based Herbicides,” which was issued on February 18, 2026. This means that any federal efforts or initiatives related to glyphosate-based herbicides that would normally be funded will not be able to proceed with federal money if this bill passes.
Legal Actions Against Glyphosate Manufacturers
Section 3 establishes a legal framework that allows individuals who have suffered harm from exposure to glyphosate or elemental phosphorus to seek compensation through civil lawsuits. The following points outline this framework:
Cause of Action:
Individuals, or their representatives, who have experienced physical injury, illness, disease, or death as a result of exposure to glyphosate can file a civil lawsuit against manufacturers, distributors, or sellers.
Covered Entities:
This includes anyone involved in the manufacturing, distribution, or sale of glyphosate-based herbicides or elemental phosphorus.
Jurisdiction:
District courts in the United States will have the authority to hear these cases regardless of the amount of money involved or the citizenship status of the parties.
Relief Options:
Victims can seek various forms of relief including:
Compensatory damages for medical expenses, lost income, pain and suffering, or wrongful death.
Punitive damages to penalize the manufacturers.
Equitable relief that might include court orders to address the harm or clarify legal rights.
Coverage for attorney’s fees and costs related to the legal action.
Immunity and Liability Waiver
Under this bill, the immunity that manufacturers may typically claim under federal laws will not protect them from lawsuits related to injuries caused by glyphosate or elemental phosphorus. This includes:
Nullification of Immunity:
Manufacturers will not be able to argue that they cannot be sued because their products were made in compliance with any federal orders or regulations.
No Federal Contractor Defense:
They cannot use the defense that they were following government contracts or directives as a basis to avoid liability.
Preservation of Existing Claims
The bill also clarifies that it does not interfere with any existing or pending legal claims related to glyphosate exposure, ensuring that individuals can continue to pursue justice without limitations imposed by this new legislation.
Applicability and State Law
This bill applies to claims that arise before, on, or after its enactment, ensuring broad coverage of legal actions. Additionally, it specifies that nothing in the Act should impact existing state laws that provide rights or remedies related to glyphosate exposure.
Relevant Companies
Bayer AG (BAYRY)
– Bayer, the parent company of Monsanto, has significant involvement with glyphosate-based products and could face increased liability and lawsuits if the bill passes.
Dow Inc. (DOW)
– Dow produces various herbicides that include glyphosate and could also be impacted by increased legal challenges.
Sysco Corporation (SYY)
– While Sysco is primarily a food distribution company, it could be indirectly affected if glyphosate is part of any of its included products or supplier agreements.
Representative Thomas Massie Bill Proposals
Here are some bills which have recently been proposed by Representative Thomas Massie:
H.R.7601: No Immunity for Glyphosate ActH.R.6508: NATO ActH.R.5811: Restoring America’s Leadership in Innovation Act of 2025H.R.5704: Repeal the Smith-Mundt Modernization Act of 2013H.R.5302: No Funds for Foreign Abortions ActH.R.5066: Safe Students Act
You can track bills proposed by Representative Thomas Massie on Quiver Quantitative’s politician page for Massie.
Representative Thomas Massie Net Worth
Quiver Quantitative estimates that Representative Thomas Massie is worth $3.1M, as of March 4th, 2026. This is the 217th highest net worth in Congress, per our live estimates.
Massie has approximately $34.2K invested in publicly traded assets which Quiver is able to track live.
You can track Representative Thomas Massie’s net worth on Quiver Quantitative’s politician page for Massie.
Representative Thomas Massie Stock Trading
We have data on up to $50.0K of trades from Representative Thomas Massie, which we parsed from STOCK Act filings. Some of the largest trades include:
A July 14th, 2020 sale of up to $50K of $TSLA. The stock has risen 288.08% since then.
You can track Representative Thomas Massie’s stock trading on Quiver Quantitative’s politician page for Massie.
2026 Kentucky’s 4th Congressional District Election
There has been approximately $13,588,156 of spending in Kentucky’s 4th congressional district elections over the last two years, per our estimates.
Approximately $8,582,930 of this has been from outside spending by PACs and Super PACs. Some of the groups who are spending money in this race include:
The rating for this race is currently “Solid R”.
You can track this election on our matchup page for the 2026 Kentucky’s 4th congressional district election.
This article is not financial advice. See Quiver Quantitative’s disclaimers for more information.
